Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Reports in the popular press suggest that smart drugs or “nootropics” such as methylphenidate, modafinil and piracetam are increasingly being used by the healthy to augment cognitive ability. Although current nootropics offer only modest improvements in cognitive performance, it appears likely that more effective compounds will be developed in the future and that their off-label use will increase. One sphere in which the use of these drugs may be commonplace is by healthy students within academia. This article reviews the ethical and pragmatic implications of nootropic use in academia by drawing parallels with issues relevant to the drugs in sport debate. It is often argued that performance-enhancing drugs should be prohibited because they create an uneven playing field. However, this appears dubious given that “unfair” advantages are already ubiquitous and generally tolerated by society. There are concerns that widespread use will indirectly coerce non-users also to employ nootropics in order to remain competitive. However, to restrict the autonomy of all people for fear that it may influence the actions of some is untenable. The use of potentially harmful drugs for the purposes of enhancement rather than treatment is often seen as unjustified, and libertarian approaches generally champion the rights of the individual in deciding if these risks are acceptable. Finally, whether the prohibition of nootropics can be effectively enforced is doubtful. As nootropics use becomes widespread among students in the future, discussion of this issue will become more pressing in the years to come.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2 Sigma Problem: The Search for Methods of Group Instruction as Effective as One-to-One Tutoring
BLOOM, B. S. (1984) · Educational Researcher · doi:10.3102/0013189x013006004 · Cited by 2,734
Devlin, B., Daniels, M., & Roeder, K. (1997) · Nature · doi:10.1038/41319 · Cited by 478 · cited 1×
“and twin studies indicate that IQ has a heritability of approximately 50%.”
BackgroundBacopa monniera, a reputed nootropic plant: An overview
Russo, A., & Borrelli, F. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.12.008 · Cited by 447 · cited 1×
“For nootropic psychostimulants such as methylphenidate, the dangers are real and relatively well known. Aside from its abuse potential, methylphenidate may aggravate mental illness, produce sleep disturbances and is associated with cerebrovascular complications.”
BackgroundCaffeine and sports performance
Burke, L. M. (2008) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h08-130 · Cited by 442 · cited 1×
“Although the dangers of drugs are often overstated, these dangers seemingly justify their prohibition because legalisation may be perceived as tacit endorsement of their use. Indeed, the safety profile of a performance-enhancing drug appears to be a large determinant of whether or not it is prohibited. Caffeine, for e…”
BackgroundIllicit use of psychostimulants among college students: A preliminary study
Low, K. G., & Gendaszek, A. E. (2002) · Psychology, Health & Medicine · doi:10.1080/13548500220139386 · Cited by 264
Cited by
Kim, T. D., Hong, G., Kim, J., & Yoon, S. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.1.1 · Cited by 65
Metadata
- Authors
- Cakic, V
- Venue
- Journal of Medical Ethics
- Publisher
- BMJ
- Published
- 2009-09-30
- Volume
- 35
- Issue
- 10
- Pages
- 611-615
- ISSN
- 0306-6800 (ISSN-L)
- 1473-4257
- OpenAlex
- W2164993409
- Cited by
- 195
- References
- 5
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.